Results 101 to 110 of about 1,368 (117)

Novel molecular targets for atrial fibrillation therapy

Nature Reviews Drug Discovery, 2012
Dobromir Dobrev, Leif Carlsson, Stanley Nattel   +2 more
exaly  

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

Lancet, The, 2015
Renate B Schnabel, Philimon N Gona, Martin G Larson   +2 more
exaly  

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Lancet, The, 2009
David R Holmes Jr, Vivek Y Reddy
exaly  

Stroke prevention in atrial fibrillation

Lancet, The, 2016
Saul B Freedman, Tatjana S Potpara, Gregory Lip   +2 more
exaly  

An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction

Lancet, The, 2019
Zachi I Attia, Peter A Noseworthy, Francisco Lopez-Jimenez   +2 more
exaly  

Catheter ablation of atrial arrhythmias: state of the art

Lancet, The, 2012
Geoffrey Lee, Prashanthan Sanders Mbbs
exaly  

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Lancet, The, 2006
Salim Yusuf
exaly  

Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

Lancet, The, 1997
Jens Cosedis Nielsen, Leif Thuesen
exaly  

Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

Lancet, The, 2000
Stefan H Hohnloser
exaly  

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Lancet, The, 2009
Timothy J Watson, Eduard Shantsila, Gregory Lip   +2 more
exaly